fluoropyrimidine, HER2-yakanaka, oxaliplatin, Iyo kambani Seagen Inc, tucatinib, Tukysa
Mvumo yekukurumidza inopihwa neFDA kune tucatinib ine trastuzumab yegomarara remukati.
Muna Kukadzi 2023, iyo Chikafu neDrug Administration (FDA) yakawedzera kubvumidzwa kwetucatinib (Tukysa, Seagen Inc.) uye trastuzumab kurapwa kweRAS yemusango-mhando HER2-positive colorectal cancer iyo yapararira kana isingakwanise kudzoreredzwa.
fluoropyrimidine, gastroesophageal junction (GEJ) adenocarcinoma, KEYTRUDA, Merck & Co, Pembrolizumab, Trastuzumab
Pembrolizumab inogamuchira mvumo yekukurumidza kubva kune iyo FDA yeHER2-yakanaka kenza yemudumbu
Nyamavhuvhu 2021: Pembrolizumab (Keytruda, Merck & Co) pamwe chete ne trastuzumab, fluoropyrimidine-, uye platinum ine chemotherapy yakapihwa mvumo yekukurumidza neKudya neDrug Administration kweiyo firs ..
Bristol Myers squibb, CHECKMATE-649, fluoropyrimidine, nivolumab, Wonderful, platinum ine chemotherapy
Nivolumab mukuwedzera kune chemotherapy inogamuchirwa neDFA kune metastatic gastric cancer uye esophageal adenocarcinoma
Nyamavhuvhu 2021: Yepamberi kana metastatic gastric cancer, gastroesophageal junction cancer, uye esophageal adenocarcinoma, Chikafu neDrug Administration yakabvumidza nivolumab (Opdivo, Bristol-Myers Squibb Company) muchibatanidzwa wit ..